It stemmed from the lack of pharmaceutical regulation in the U.S. and, above all, from the absence of a universal public healthcare system.
None of this is solved with tariffs; it only makes things worse.
It stemmed from the lack of pharmaceutical regulation in the U.S. and, above all, from the absence of a universal public healthcare system.
None of this is solved with tariffs; it only makes things worse.
www.nytimes.com/2025/02/01/u...
www.nytimes.com/2025/02/01/u...
www.nytimes.com/2025/02/01/u...
www.nytimes.com/2025/02/01/u...